CUE icon

Cue Biopharma

39 hedge funds and large institutions have $37.4M invested in Cue Biopharma in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$5.78M
2 +$5.02M
3 +$2.57M
4
Northern Trust
Northern Trust
Illinois
+$1.25M
5
State Street
State Street
Massachusetts
+$1.18M

Top Sellers

1 -$3.62M
2 -$410K
3 -$232K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$13.4K
5
Barclays
Barclays
United Kingdom
-$6.36K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.5M
2
$7.93M
3
$5.02M
4
$2.58M
5
$2.31M
6
$2.14M
7
$1.3M
8
$527K
9
$484K
10
$460K
11
$402K
12
$393K
13
$356K
14
$321K
15
$275K
16
$263K
17
$255K
18
$246K
19
$234K
20
$231K
21
$188K
22
$179K
23
$166K
24
$147K
25
$137K